Marta Brambilla

Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis

Biagio Ricciuti, Carlo Genova, Andrea De Giglio et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 357 citations · Full text

Medicine, Immunology, Multi-institutional Analysis +8

The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors

Francesca Corti, Sara Lonardi, Rossana Intini et al. · European Journal of Cancer · 2021 · 102 citations

Pan-immune-inflammation Value, Cancer Immunosurveillance, Medicine +12

EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort

Arsela Prelaj, Roberto Ferrara, Sara Elena Rebuzzi et al. · Cancers · 2019 · 77 citations · Full text

Immunology, Immunotherapeutics, Immunotherapy +21

Landslide risk analysis: a multi-disciplinary methodological approach

Simone Sterlacchini, Simone Frigerio, P. Giacomelli et al. · Natural hazards and earth system sciences · 2007 · 65 citations · Full text

Risk Assessment, Rock Slide, Engineering +15

Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program

Arsela Prelaj, Achille Bottiglieri, Claudia Proto et al. · European Journal of Cancer · 2021 · 57 citations

Advanced Nsclc, Genetic Disorder, Medicine +9